A Phase II Clinical Trial of Panitumumab in Combination with Infusional Oxaliplatin and Oral Capecitabine (XELOX) Chemotherapy as 1st line Therapy in Patients with Colorectal Cancer and Advanced Liver Metastases.
Phase of Trial: Phase II
Latest Information Update: 14 Sep 2015
At a glance
- Drugs Capecitabine (Primary) ; Oxaliplatin (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer; Liver metastases
- Focus Therapeutic Use
- 12 Sep 2015 Status changed from recruiting to completed as per European Clinical Trials Database record.
- 09 Jul 2011 New trial record